Triamcinolone acetonide hydrofluoroalkane inhalation - Abbott Laboratories
Alternative Names: Azmacort HFA; Azmacort HFA-134a; KI 03216; RG 5016; Triamcinolone acetonide HFA inhalation - Abbott Laboratories; Triamcinolone acetonide HFA inhalation - KosLatest Information Update: 05 Nov 2021
At a glance
- Originator Aventis
- Developer Abbott Laboratories
- Class Analgesics; Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics; Antirheumatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Pregnadienes; Small molecules
- Mechanism of Action Immunosuppressants; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Asthma